0001282304-12-000001.txt : 20121226
0001282304-12-000001.hdr.sgml : 20121226
20121226174630
ACCESSION NUMBER: 0001282304-12-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121218
FILED AS OF DATE: 20121226
DATE AS OF CHANGE: 20121226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KERSTEN GEERT R
CENTRAL INDEX KEY: 0001236030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 121285958
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2012-12-18
0
0000725363
CEL SCI CORP
cvm
0001236030
KERSTEN GEERT R
1
1
0
0
Chief Executive Officer
Options
0.28
2012-12-18
4
A
0
2300000
0
A
2013-12-18
2022-12-17
Common Stock
2300000
13283009
D
Options
0.28
2012-12-18
4
A
0
2700000
0
A
2022-12-17
Common Stock
2700000
15983009
D
Options
0.22
2012-12-18
4
D
0
1890000
0
D
2004-04-01
2013-04-01
Common Stock
1890000
14093009
D
Options
0.28
2012-12-18
4
A
0
1890000
0
A
2012-12-18
2017-12-17
Common Stock
1890000
15983009
D
Equally and annually over 5 years
Shares Exercisable Date
110,770 12-18-13
110,770 12-18-14
354,090 12-18-15
354,085 12-18-16
354,085 12-18-17
354,085 12-18-18
354,085 12-18-19
354,085 12-18-20
354,085 12-18-21
Replacement of cancelled options at higher exercise price in return for extended expiration date
Geert Kersten
2012-12-26